72606-022Nov 30, 2023 Adalimumab 40 mg/.4ml Subcutaneous Injection by Celltrion USA, Inc.
72606-040Nov 30, 2023 Adalimumab 80 mg/.8ml Subcutaneous Injection by Celltrion USA, Inc.
72606-041Nov 30, 2023 Adalimumab 20 mg/.2ml Subcutaneous Injection by Celltrion USA, Inc.
83257-020Apr 15, 2024 AdalimumabAdalimumab Kit by Biocon Biologics Inc
83257-021Apr 15, 2024 AdalimumabAdalimumab Kit by Biocon Biologics Inc
83257-022Apr 15, 2024 AdalimumabAdalimumab Kit by Biocon Biologics Inc
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.